【投融资动态】博诺康源B++轮融资，投资方为常熟国发创投

Core Insights - Bonokangyuan (Beijing) Pharmaceutical Technology Co., Ltd. has completed a B++ round of financing, with the amount undisclosed, and the investment was led by Changshu Guofa Venture Capital [1][2] Company Overview - Bonokangyuan was established in 2016 with a registered capital of 10 million [2] - The company has a construction area of approximately 3,100 square meters, which includes various laboratories for synthesis, analysis, formulation preparation, and biological testing [2] - Located in the Beijing Economic Development Zone, the company is situated in a hub for pharmaceutical research and development, surrounded by numerous R&D companies and complete supporting facilities [2] - The primary business focus is on high-end generic drugs and innovative drugs for oncology and respiratory systems [2] - As of mid-2017, the company had 34 R&D personnel and a total investment of 40 million [2]